Vertex Pharmaceuticals Inc
XBER:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XBER:VX1
|
US |
|
H
|
HeidelbergCement AG
F:HEI
|
DE |
|
H
|
Honeywell International Inc
DUS:ALD
|
US |
|
N
|
Nikon Corp
XHAM:NKN
|
JP |
|
C
|
Cashbuild Ltd
XBER:C8J
|
ZA |
|
National Beverage Corp
NASDAQ:FIZZ
|
US |
|
P
|
Panasonic Holdings Corp
DUS:MAT1
|
JP |
|
F
|
Fresenius SE & Co KGaA
F:FREA
|
DE |
|
R
|
Ross Stores Inc
BMV:ROST
|
US |
|
C
|
CVS Health Corp
SWB:CVS
|
US |
|
P
|
Panasonic Holdings Corp
XMUN:MAT1
|
JP |
|
Bilfinger SE
F:GBF
|
DE |
|
D
|
Delta Air Lines Inc
SWB:OYC
|
US |
|
A
|
Abercrombie & Fitch Co
XBER:AFT
|
US |
|
B
|
Budweiser Brewing Company APAC Ltd
OTC:BDWBF
|
HK |
|
P
|
Proto Labs Inc
F:PRZ
|
US |
|
U
|
United Utilities Group PLC
F:UUEC
|
UK |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 535.06 EUR with a low forecast of 319.25 EUR and a high forecast of 644.68 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
535.06
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 535.06 EUR with a low forecast of 319.25 EUR and a high forecast of 644.68 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Net Income over the next 8 years is 15%.
